Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Seneschal

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Clinical and Experimental Dermatology|April 22, 2026
The Long-Term Impact of Childhood and Adolescent Atopic Dermatitis on Physical and Psychosocial Well-Being: Scars of Life projectThomas Luger, Roberto Takaoka, Jerry Tan, et al.
Immunity|June 14, 2015
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper ResponseClément Jacquemin, Nathalie Schmitt, Cécile Contin-Bordes, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2024
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective StudyAlexandre Beyrouti, Juliette Deuze, Eric Fontas, et al.
Haematologica|February 16, 2015
CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorderGuillaume Lefèvre, Marie-Christine Copin, Christophe Roumier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2022
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry TaskforceAngela L Bosma, Annelie H Musters, Manja Bloem, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 2, 2023
Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patientsIngrid Costedoat, Martin Wallaert, Aurelie Gaultier, et al.
The Journal of Dermatological Treatment|October 10, 2025
Assessment of vitiligo in clinical practice: a cross-sectional survey among expertsJolien Duponselle, Marlide R Jukema, Albert Wolkerstorfer, et al.
JAMA Dermatology|March 25, 2026
Definition of Severity and Relapse for Vitiligo: An International Consensus StatementViktoria Eleftheriadou, Seemal Desai, Jung Min Bae, et al.
Pigment Cell & Melanoma Research|November 20, 2016
Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus ConferenceEmily Y Gan, Viktoria Eleftheriadou, Samia Esmat, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 25, 2023
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithmNanja van Geel, Reinhart Speeckaert, Alain Taïeb, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Clinical and Experimental Dermatology|April 22, 2026
The Long-Term Impact of Childhood and Adolescent Atopic Dermatitis on Physical and Psychosocial Well-Being: Scars of Life projectThomas Luger, Roberto Takaoka, Jerry Tan, et al.
Immunity|June 14, 2015
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper ResponseClément Jacquemin, Nathalie Schmitt, Cécile Contin-Bordes, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2024
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective StudyAlexandre Beyrouti, Juliette Deuze, Eric Fontas, et al.
Haematologica|February 16, 2015
CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorderGuillaume Lefèvre, Marie-Christine Copin, Christophe Roumier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2022
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry TaskforceAngela L Bosma, Annelie H Musters, Manja Bloem, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 2, 2023
Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patientsIngrid Costedoat, Martin Wallaert, Aurelie Gaultier, et al.
The Journal of Dermatological Treatment|October 10, 2025
Assessment of vitiligo in clinical practice: a cross-sectional survey among expertsJolien Duponselle, Marlide R Jukema, Albert Wolkerstorfer, et al.
JAMA Dermatology|March 25, 2026
Definition of Severity and Relapse for Vitiligo: An International Consensus StatementViktoria Eleftheriadou, Seemal Desai, Jung Min Bae, et al.
Pigment Cell & Melanoma Research|November 20, 2016
Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus ConferenceEmily Y Gan, Viktoria Eleftheriadou, Samia Esmat, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 25, 2023
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithmNanja van Geel, Reinhart Speeckaert, Alain Taïeb, et al.
Pageof 19